Transposase with enhanced insertion site selection properties
CA3052895A1
Novel vaccinia virus vectors related to mva with extensive genomic symmetries
WO2018086686A1
Novel porcine cell line for virus production
BR112015006798A2
modified ankara vaccinia virus, genome, cell, methods for culturing a mva virus, for producing a mva virus and for producing a recombinant mva virus, pharmaceutical composition, vaccine, mva virus or genome, and nucleic acid molecule
AU2012264696A1
Methods for preparation of fucose-linked site specific conjugates of proteins with toxins, adjuvants, detection labels and pharmacokinetic half life extenders
WO2012152945A1
Enhancement of protein production yield mediated by a fast shuttling cdc42 gtpase
WO2012069190A2
Depletion of host cell components from live virus vaccines
MY160680A
Process for producing molecules containing specialized glycan structures
WO2009156155A1
Cell line for propagation of highly attenuated alphaviruses
EP2265712A1
Cell line from rousettus as host cell for pathogen amplification
EP2199385A1
Specific and persistent activation of heat shock response in cell lines using a viral factor
CN101918533A
Composition for the release and protection of instant active dry yeasts
WO2009024595A2
Culture system and method for immunogenicity and immunofunction testing in vitro
EP2098590A1
Cell line from Rousettus as host cell for pathogen amplification
US2009286317A1
Modular culture system for maintenance, differentiation and proliferation of cells
WO2008101542A1
Synthetic polyamino acids, method of their production and use thereof
WO2006120202A1
Simultaneous parameter evaluation device for cell cultivation processes
EP1783210A1
Productivity augmenting protein factors, novel cell lines and uses thereof
US2006019391A1
Liquid-gas-phase exposure reactor for cell culturing
